ReviewSkeletal radiology2026
Assessing bone microstructure and density with photon-counting CT: emerging applications and challenges.
Review in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Photon-counting computed tomography (PCCT) represents a transformative advancement in bone imaging, compared to conventional energy-integrating detector CT offering superior spatial and contrast resolution, enhanced dose efficiency, and the unique capability to perform both ultra-high-resolution and material decomposition imaging in a single acquisition. This review provides a technical overview and synthesizes evidence from preclinical studies, demonstrating that PCCT offers the possibility of accurate quantification of bone microarchitecture and mineral density with performance similar to high-resolution peripheral quantitative CT. However, translating these benefits to in vivo clinical imaging remains challenging due to the need to balance image quality with acceptable radiation dose. Further research is required to validate PCCT for cortical and trabecular bone analysis in patients. Beyond structural assessment, PCCT facilitates advanced applications such as bone marrow fat quantification and opportunistic osteoporosis screening, with early clinical studies showing strong agreement with established standards. While PCCT holds significant promise for revolutionizing bone research and clinical practice, widespread adoption will depend on optimization of image acquisition protocols, standardized image processing and analysis, and additional clinical validation.
Indexed as
Identifiers
41998410What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.